For more than 1.5 million Australians living with diabetes, managing their condition is a relentless, 24-hour responsibility.
A lack of up-to-date New Zealand research into common gut disorders means the country is effectively flying blind on ...
Results from the AURORAS-1 Phase I clinical trial of an anticancer drug called ERAS-0015 have shown that it is safe and has ...
New research suggests health officials may be overselling the protective power of the annual flu shot—but that doesn't mean ...
You may not love the taste of a certain soda, yet you can still find yourself gravitating toward it when you spot the logo.
Researchers at Lund University in Sweden have identified a key role for the protein galectin-3 in Alzheimer's disease. The ...
For the one-in-five Americans with a mental health condition, the options for treatment aren't too much different from what ...
For more than two decades, azacitidine has been a major treatment for blood cancers such as high-risk myelodysplastic ...
Daraxonrasib combined with chemotherapy caused substantial tumor shrinkage in patients with pancreatic cancer that had spread ...
In a large, international study analyzing data from over 1 million people, researchers identified multiple genomic regions, ...
A new study from Monash University has uncovered a genetic blueprint of immune aging, shedding light on why our bodies become ...
High blood sugar, a major problem in type 2 diabetes, could become part of the solution in monitoring the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results